Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.36 (
hyaluronidase
)
4,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pasteurella multocida was isolated from 42 of the 135 (31%) deep nasal swabs from clinically healthy conventional rabbits supplied by two vendors. The prevalences were significantly different among sex, age, and sources. The females and adults had higher prevalences when compared to males and juveniles, respectively. One vendor's rabbits had a prevalence of 41% while the other had 20%. Biochemically, only 24% of the 42 isolates decarboxylated L-
ornithine
, and 55% produced indol. All isolates were sensitive in vitro to several of the commonly used antibiotics, but most isolates were resistant to lincomycin, streptomycin, and sulfonamides. Typing with a
hyaluronidase
inhibition test revealed that 28 of the 42 (67%) isolates were type A. Type A was the major type isolate, whether the samples came from healthy rabbits or from rabbits with pyogenic lesions. The acriflavine flocculation test showed that two of the 42 (5%) isolates were type D. Although none of the 42 isolates were positive to both hyalurondase and acriflavine tests, 12 of the 42 (29%) isolates were negative to both tests, indicating that these isolates were not typeable by these two methods. The demonstration of more than one capsular type of Pasteurella multocida in rabbits indicates the need for more extensive studies on this important rabbit pathogen.
...
PMID:Characterization of Pasteurella multocida isolates from the nares of healthy rabbits with pneumonia. 75 Jul 29
Pro-inflammatory effects of cationic proteins secreted by human granulocytes include induction of increased vascular permeability and oedema, which are likely to be mediated by damage to vascular endothelium. We have shown previously that a series of synthetic polycationic amino acids produce a dose-, time- and Mr-dependent inhibition of [3H]leucine or [3H]thymidine incorporation into macromolecules by human umbilical vein endothelial cells, and that the extent of inhibition was correlated with changes in cell morphology, with release of cytoplasmic constituents and was irreversible. The experiments reported here characterise further the requirements for the induction of cytotoxicity by polycations. We have found that the extent of inhibition is related to both the identity of the monomer, for polymers of Mr 40,000 the order is
ornithine
greater than lysine greater than arginine, and to its configuration; poly-D-lysines are more potent inhibitors than poly-L-lysines of similar Mr. Only brief exposure to the agonist is required, 90% inhibition occurred after 10 min of exposure to poly-L-lysine (Mr 90,000). Treatment of endothelial cells with neuraminidase, heparinase,
hyaluronidase
, chondroitinase or trypsin did not reduce their susceptibility to polylysine. Inhibition of microtubule or microfilament formation also had no effect on polylysine cytotoxicity, indicating that internalisation of the polymer was not a prerequisite for the effect. Inhibition of protein synthesis or pretreatment with simple sugars likewise failed to block the effects of polylysine treatment. Natural cationic proteins exerted similar effects on endothelial cells, the extent of the effect apparently being related to the pI of the protein.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Biochemical characterisation of polycation-induced cytotoxicity to human vascular endothelial cells. 263 82